Development and Biochemical Characterization of Self-Immolative Linker Containing GnRH-III-Drug Conjugates
The human gonadotropin releasing hormone (GnRH-I) and its sea lamprey analogue GnRH-III specifically bind to GnRH receptors on cancer cells and can be used as targeting moieties for targeted tumor therapy. Considering that the selective release of drugs in cancer cells is of high relevance, we were...
Main Authors: | Gennari, C. (Author), Halmos, G. (Author), Juhász, É (Author), Mező, G. (Author), Neundorf, I. (Author), Schuster, S. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification
by: Sabine Schuster, et al.
Published: (2018-11-01) -
Apoptotic Effects of Drug Targeting Conjugates Containing Different GnRH Analogs on Colon Carcinoma Cells
by: Eszter Lajkó, et al.
Published: (2019-09-01) -
Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice
by: Ivan Ranđelović, et al.
Published: (2019-09-01) -
Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery
by: Sabine Schuster, et al.
Published: (2018-04-01) -
Suitability of GnRH Receptors for Targeted Photodynamic Therapy in Head and Neck Cancers
by: Lilla Pethő, et al.
Published: (2019-10-01)